Wedbush Issues Pessimistic Estimate for Biogen Earnings
Biogen Inc. (NASDAQ:BIIB – Free Report) – Investment analysts at Wedbush lowered their Q1 2025 EPS estimates for Biogen in a research note issued on Thursday, February 13th. Wedbush analyst L. Chico now expects that the biotechnology company will post earnings of $3.82 per share for the quarter, down from their previous forecast of $3.97. […]
Biogen Inc. (NASDAQ:BIIB – Free Report) – Investment analysts at Wedbush lowered their Q1 2025 EPS estimates for Biogen in a research note issued on Thursday, February 13th. Wedbush analyst L. Chico now expects that the biotechnology company will post earnings of $3.82 per share for the quarter, down from their previous forecast of $3.97. […]
